Brief: Nextcell Pharma To Implement Strategic Changes

NextCell Pharma AB

27/02/2024 08:08

Feb 27 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * TODAY ANNOUNCES THAT COMPANY HAS DECIDED TO IMPLEMENT STRATEGIC CHANGES
    * NEW STRATEGIC DIRECTION MEANS, AMONGST OTHER THINGS, THAT CELLAVIVA WILL BECOME A WHOLLY
OWNED
SUBSIDIARY AND THAT COMPANY'S GMP FACILITY WILL HAVE NEW SOURCES OF REVENUE
    * STRATEGIC CHANGES WILL ALSO RESULT IN COST SAVINGS AS A RESULT OF STAFF REDUCTION
    * AS PART OF NEW DIRECTION, NEXTCELL HAS DECIDED ON STAFF REDUCTIONS

Source text for Eikon:  ID:nWkr2tCF6D 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))